Apple (AAPL) releases COVID-19 app, website based on CDC guidance
Get Alerts AAPL Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.3%
Revenue Growth %: +10.4%
Join SI Premium – FREE
Apple (NASDAQ: AAPL) has launched a new app and a website hosting resources to help people stay informed and take the proper steps to protect their health during the spread of COVID-19.
Apple's COVID-19 app helps users assess risk factors, recent exposure, and symptoms. Following answering the questionnaire, the app will provide CDC recommendations on next steps, including whether or not a test is recommended at this time, and when to contact a medical provider.
Users of the app, or visitors to the website will receive answers to frequently asked questions about COVID-19, including who is most at risk and how to recognize symptoms. In addition, they will learn the most up-to-date information from the CDC like best practices for washing hands, disinfecting surfaces, and monitoring symptoms.
The new COVID-19 app, available on the App Store, and website were created in partnership with the CDC1, the Coronavirus Task Force and FEMA to make it easy for people across the country US to get trusted information and guidance at a time when the US healthcare system is feeling the heavy burden of COVID-19.
The COVID-19 app and website were built to keep all user data private and secure. The tools do not require a sign-in or association with a user's Apple ID, and users' individual responses will not be sent to Apple or any government organization.
Apple also notes that travelers landing at select international airports throughout the US started receiving notifications.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Reiterates Neutral Rating on Apple (AAPL)
- Citi sees eSSD demand to jump 52.9% in 2027 on AI growth
- Quantum eMotion receives U.S. patent notice for SecureKey technology
Create E-mail Alert Related Categories
Corporate News, General NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share